Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0002010585-24-000001
Filing Date
2024-02-07
Accepted
2024-02-07 16:21:10
Documents
1
Effectiveness Date
2024-02-07
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 11874
  Complete submission text file 0002010585-24-000001.txt   13386
Mailing Address 12117 BEE CAVES ROAD BUILDING THREE SUITE 100 AUSTIN TX 78738
Business Address 12117 BEE CAVES ROAD BUILDING THREE SUITE 100 AUSTIN TX 78738 512-519-0400
Aspira Women's Health Inc. (Filer) CIK: 0000926617 (see all company filings)

EIN.: 330595156 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-504653 | Film No.: 24604628
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)